Prescribing for thrombophilia--are we going to repeat mistakes of the past?
Jivraj
Shehnaaz
S
D000026:Abortion, Habitual / Q000209:etiology / Q000517:prevention & control*; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000009:adverse effects; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects; D005165:Factor V / Q000235:genetics; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000639:trends*; D011247:Pregnancy; D011256:Pregnancy Outcome; D016032:Randomized Controlled Trials as Topic; D019851:Thrombophilia / Q000150:complications / Q000188:drug therapy* / Q000235:genetics
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D004968:Estrogens, Non-Steroidal; C095381:factor V Leiden; D004054:Diethylstilbestrol; D005165:Factor V; D006493:Heparin; D001241:Aspirin